These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8657230)

  • 1. Campylobacter jejuni Infection and treatment for Guillain-Barré Syndrome.
    Jacobs BC; Schmitz PI; van der Meche FG
    N Engl J Med; 1996 Jul; 335(3):208-9. PubMed ID: 8657230
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
    van der Meché FG; Visser LH; Jacobs BC; Endtz HP; Meulstee J; van Doorn PA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S99-102. PubMed ID: 9396690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome].
    Yuki N
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):612-6. PubMed ID: 9627467
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of axonal form of Guillain-Barré syndrome associated with anti-GM1b IgG antibody following Penner 4 Campylobacter jejuni infection].
    Nagayama S; Kurohara K; Matsui M; Kuroda Y; Kusunoki S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):506-8. PubMed ID: 9366179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody.
    Saito T
    Intern Med; 2002 Oct; 41(10):760-1. PubMed ID: 12412991
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome associated with Campylobacter infection.
    Kuroki S; Haruta T; Yoshioka M; Kobayashi Y; Nukina M; Nakanishi H
    Pediatr Infect Dis J; 1991 Feb; 10(2):149-51. PubMed ID: 2062607
    [No Abstract]   [Full Text] [Related]  

  • 12. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré syndrome and infection].
    Saida T; Hao Q; Obayashi H; Nishimura K; Ozawa K; Saida K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1378-9. PubMed ID: 8752403
    [No Abstract]   [Full Text] [Related]  

  • 14. Campylobacter jejuni and Guillain-Barré syndrome.
    Rees JH; Hughes RA
    Ann Neurol; 1994 Feb; 35(2):248-9. PubMed ID: 8109911
    [No Abstract]   [Full Text] [Related]  

  • 15. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
    Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
    Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Guillain-Barré syndrome associated with Campylobacter jejuni infection with failure to respond to plasmapheresis and immunoglobulin.
    Allen A; Antony SJ
    J Am Board Fam Pract; 1999; 12(3):249-52. PubMed ID: 10395423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenesis of Guillain-Barre syndrome and its relation with Campylobacter jejuni].
    Li H; Shen B; Yuan J
    Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):776-8. PubMed ID: 9592345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.